Results 131 to 140 of about 3,496 (176)

Pharmacogenetic exploration of buprenorphine and related metabolites in umbilical cord blood. [PDF]

Toxicol Rep
Monfared A, Murrell DE, Shah DS, Hoang M, Brown SD, Harirforoosh S.   +5 more
europepmc   +1 more source

Mixed-Methods Study With a Systematic Review of Personalized Drug Therapy Approaches and Survey Analysis of Pharmacogenomics in Internal Medicine. [PDF]

Cureus
Elachola MS, Sasikumarame AP, Lashari UG, Nazeer H, Koduvayalil RH, Fathima H, Ponnumundasseri SK, Ririe AK.   +7 more
europepmc   +1 more source

A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications. [PDF]

NPJ Genom Med
Shorbaji A, Pushparaj PN, Al-Ghafari AB, Mira LS, Basabrain MA, Naseer MI, Ahmed F, Abu-Elmagd M, Rasool M, Bakhashab S.   +9 more
europepmc   +1 more source

Anticoagulation Therapies and microRNAs in Heart Failure. [PDF]

Biomolecules
Spartano L, Lombardi M, Foglieni C.
europepmc   +1 more source

Estimating the Frequency of False-Negative Pharmacogenetic Test Results by Self-Reported Ancestry. [PDF]

Clin Pharmacol Ther
Siu WS, Maruf AA, Shaheen SM, McCloud R, Heintz M, McAusland L, Arnold PD, Bousman CA.   +7 more
europepmc   +1 more source

Pharmacogenomic diversity among Arab populations: A systematic review. [PDF]

iScience
Al-Mahayri ZN, Alqasrawi MN, Khasawneh LQ, Altoum SM, Albawa'neh AS, Dabaghie L, Ali BR.   +6 more
europepmc   +1 more source

Retrospective modeling study of ChatGPT (GPT 4) warfarin dose adjustment in patients with INRs outside the therapeutic range. [PDF]

Digit Health
Tezcan H, Tunçez A, Özen Y, Yalçın MU, Gürses KM.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

VKORC1 and CYP2C9 genotype distribution in Asian countries

Thrombosis Research, 2014
Warfarin is the most widely used anticoagulant all over the world for prevention and treatment of different thrombotic conditions. Polymorphisms in two genes i.e. CYP2C9 (Cytochrome P450 2C9) and VKORC1 (Vitamin K epoxide reductase complex subunit 1) play a major role in warfarin dose variation and its related adverse effects.
Kanjaksha Ghosh, Shrimati Shetty
exaly   +3 more sources

Genetic Variation in VKORC1 and Risk for Osteoporosis

Archives of Medical Research, 2021
The vitamin K epoxide reductase complex subunit 1 (VKORC1) plays an important role in bone development and bone metabolism by influencing the vitamin K cycle. The aim of this study was to investigate the association between VKORC1 gene polymorphisms and bone mineral density and the risk of osteoporosis.We determined VKORC1 gene polymorphisms (rs9923231
Jin, He, Hua, Xie, Chengyuan, Yan, Yawen, Sun, Zhonghua, Xu, Xing, Zhang   +5 more
openaire   +2 more sources